These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7511837)

  • 1. [The clinical efficacy of verapamil in ventricular extrasystolic arrhythmia and parasystole].
    Lipnitskiĭ TN; Denisiuk VI; Kolesnik PF; Sizova MP; Ivanov VP; Stoliarchuk VA
    Ter Arkh; 1993; 65(12):42-4. PubMed ID: 7511837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapy of ventricular extrasystoles with Cordichin].
    Philipp H
    Med Welt; 1982 Sep; 33(36):1245-7. PubMed ID: 6182441
    [No Abstract]   [Full Text] [Related]  

  • 3. [A method for the individual choice of anti-arrhythmia preparations in extrasystole].
    Lipnitskiĭ TN; Denisiuk VI; Kolesnik PF; Muravitskiĭ OV; Sizova MP
    Lik Sprava; 1992 Jun; (6):74-6. PubMed ID: 1280888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Deterioration in ventricular arrhythmia caused by anti-arrhythmia preparations].
    Mazur NA; Kurbanov RD
    Ter Arkh; 1984; 56(9):67-70. PubMed ID: 6083611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemodynamic and clinical studies with Bonnecor--a new anti-arrhythmia drug].
    Assmann I; Kassel P; von Knorre G
    Z Gesamte Inn Med; 1990 Dec; 45(23):703-8. PubMed ID: 1714669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of ventricular arrhythmia resistant to sodium channel blockaders].
    Shpektor AV; Susliak NN
    Kardiologiia; 1991 Mar; 31(3):48-50. PubMed ID: 1714981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Response of ventricular extrasystolic arrhythmia to the action of verapamil. Evaluation by the Holter system].
    Timoner M; Forti N; Formícola A; Giannini SD
    Arq Bras Cardiol; 1978 Feb; 31 Suppl 1():79-82. PubMed ID: 79411
    [No Abstract]   [Full Text] [Related]  

  • 8. [Ventricular tachycardia in bursts. Electrophysiological and therapeutical study].
    Coumel P; Leclercq JF; Attuel P; Rosengarten M; Milosevic D; Slama R; Bouvrain Y
    Arch Mal Coeur Vaiss; 1980 Feb; 73(2):153-64. PubMed ID: 6155108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of verapamil in ventricular premature beats of acute myocardial infarction.
    Fazzini PF; Marchi F; Pucci P
    Acta Cardiol; 1978; 33(1):25-9. PubMed ID: 79283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Idiopathic ventricular tachycardia with onset in the verapamil-sensitive left ventricle: the clinical characteristics and long-term follow-up of 37 patients].
    Gaita F; Giustetto C; Libero L; Riccardi R; Bocchiardo M; Scaglione M; Lamberti F; Richiardi E; Brusca A; Massa R
    G Ital Cardiol; 1995 Jun; 25(6):695-706. PubMed ID: 7649418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathophysiological analysis and treatment of arrhythmias, using Holter electrocardiography].
    Nakanishi T; Takahashi H; Yoshimura M
    Rinsho Byori; 1990 Oct; 38(10):1103-13. PubMed ID: 1702165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Spontaneous variability of ventricular arrhythmias and evaluation of antiarrhythmic drug efficacy--studies evaluating the correlation between ventricular ectopic beat frequency and heart rate].
    Ito M; Tsumabuki S; Maeda Y; Arita M
    Rinsho Byori; 1986 Aug; 34(8):939-48. PubMed ID: 2431174
    [No Abstract]   [Full Text] [Related]  

  • 13. [The anti-arrhythmic efficacy of sodium valproate].
    Meerson FZ; Gimrikh EO; Gutsol LIa; Popov SV; Plekhanov IG
    Kardiologiia; 1992 Jul; 32(7-8):19-21. PubMed ID: 1283179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The comparative efficacy of verapamil, nifedipine and propranolol in patients with IHD and an enhanced risk of a fatal outcome].
    Mazur NA; Pavlova TS; Vasil'eva NN; Kul'ginskaia IV
    Ter Arkh; 1994; 66(8):26-30. PubMed ID: 7527161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A new method for the evaluation of the success of anti-arrhythmic drug therapy and a paradoxical drug-induced arrhythmogenic effect in individual patients].
    Andresen D; von Leitner ER; Wegscheider K; Schröder R
    Z Kardiol; 1984 Aug; 73(8):492-7. PubMed ID: 6208699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical studies with propafenone--a new antiarrhythmic agent.
    Prabhakaran SN; Bhatia ML
    Indian Heart J; 1984; 36(2):107-10. PubMed ID: 6202621
    [No Abstract]   [Full Text] [Related]  

  • 17. [The efficacy of propaphenol in extrasystole in patients with ischemic heart disease].
    Dobrotvorskaia TE; Rybakova MK; Suprun EK; Arifullin ShS
    Ter Arkh; 1992; 64(12):30-2. PubMed ID: 1284005
    [No Abstract]   [Full Text] [Related]  

  • 18. [Optimization of the use of etmozin in treating patients suffering from frequent ventricular extrasystole].
    Bugriĭ EM; Mazur NA; Pavlova TS; Dzhishambaev ED
    Ter Arkh; 1986; 58(6):62-5. PubMed ID: 2429379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy and limits of magnesium therapy in extrasystole].
    Pignide L; Hersch R
    Magnesium; 1985; 4(5-6):272-9. PubMed ID: 2422503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Idiopathic ventricular extrasystole : right ventricular parasystole not protected from the sinus rhythm?].
    Leclercq JF; Rosengarten MD; Attuel P; Coumel P; Slama R
    Arch Mal Coeur Vaiss; 1981 Nov; 74(11):1249-61. PubMed ID: 6172085
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.